{
  "story_id": "542ea628b6e7da646a1a44be9e60de60",
  "desk": "drm3",
  "revision": 1,
  "published_at": "2026-09-02T15:15:25.000Z",
  "content_hash": "5bbec0865710dba4d108441ac5b41f2dacf539aae38917c37843c90412cbcc03",
  "hash_basis": "sha256 over `headline\\ndek\\nprose`, plus `\\n` + the canonical citations JSON when any source is placed, plus `\\n#blog` for blogs",
  "basis": {
    "headline": "Thyme Care Raises $125M Series E, Launches Parent Entity",
    "dek": "Thyme Care closes a $125M Series E round led by Morgan Health and establishes a new parent company.",
    "prose": "Thyme Care announced a new Series E financing round of over $125 million. [^1]\n\nMorgan Health led the financing round with participation from Humana, CVS Health Ventures, AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures, and a16z Bio + Health. [^2]\n\nThyme Care is establishing Thyme Companies, a newly formed parent entity designed to build a portfolio of new, independent businesses in oncology. [^3]\n\nThyme Care services are currently available to more than 10.5 million people across all 50 states. [^4]\n\nThyme Care is forming a new parent company called Thyme Companies to address disconnections in how cancer care is delivered, accessed, and paid for. [^5]\n\nThyme Care's valuation reached more than $2 billion following the Series E round, roughly doubling its valuation from a Series D less than a year ago. [^6]",
    "cited": "[{\"statement\":\"Thyme Care announced a new Series E financing round of over $125 million.\",\"source\":\"Cision PR Newswire\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T15:00:00.000Z\",\"publisher_count\":1,\"sources\":[\"Cision PR Newswire\"]},{\"statement\":\"Morgan Health led the financing round with participation from Humana, CVS Health Ventures, AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures, and a16z Bio + Health.\",\"source\":\"Cision PR Newswire\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T15:00:00.000Z\",\"publisher_count\":1,\"sources\":[\"Cision PR Newswire\"]},{\"statement\":\"Thyme Care is establishing Thyme Companies, a newly formed parent entity designed to build a portfolio of new, independent businesses in oncology.\",\"source\":\"Cision PR Newswire\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T15:00:00.000Z\",\"publisher_count\":1,\"sources\":[\"Cision PR Newswire\"]},{\"statement\":\"Thyme Care services are currently available to more than 10.5 million people across all 50 states.\",\"source\":\"Cision PR Newswire\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T15:00:00.000Z\",\"publisher_count\":1,\"sources\":[\"Cision PR Newswire\"]},{\"statement\":\"Thyme Care is forming a new parent company called Thyme Companies to address disconnections in how cancer care is delivered, accessed, and paid for.\",\"source\":\"CNBC\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T15:15:25.000Z\",\"publisher_count\":1,\"sources\":[\"CNBC\"]},{\"statement\":\"Thyme Care's valuation reached more than $2 billion following the Series E round, roughly doubling its valuation from a Series D less than a year ago.\",\"source\":\"CNBC\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T15:15:25.000Z\",\"publisher_count\":1,\"sources\":[\"CNBC\"]}]",
    "kind": "news"
  },
  "receipt_verify": "Ed25519 over the dot-joined string `slice_hash.cursor_from.cursor_to.view.view_version.row_count`; public_key and sig are base64url of the raw 32-byte key / 64-byte signature",
  "receipt": null,
  "receipt_note": "this revision predates receipt-keeping (before v0.37.0); the filed row lives in the record",
  "generation_chain": {
    "wire": {
      "stream": "fountain_news",
      "story_id": "6adc77265a56fd6b6c3348a26958b9fd",
      "thread_id": "80a38ca760900b6abe9cc86cdf1b10c6",
      "thread_label": "Bobby Green",
      "novelty": "UPDATE",
      "content_hash": "be69e1c7d9ff2f509d55136b8a0789127afd777ff31e7eae798ebe9f540aca50",
      "last_published_at": "2026-09-02T15:15:25.000Z",
      "read_receipt": {
        "slice_hash": "faf23080a3705a54c4455c920d3885a108cf8d511e9854869962a86b07846359",
        "cursor_from": "eyJ0cyI6IjIwMjYtMDktMDJUMTQ6NTY6MDAuMDAwMDAwWiIsImlkIjoiOTU0NGI0NzI4MTExNzc5ZjNlMWNkYTc2OTkzMDdiNTEiLCJ2IjoiMSJ9",
        "cursor_to": "eyJ0cyI6IjIwMjYtMDktMDJUMTU6MjA6MTguMDAwMDAwWiIsImlkIjoiNzZlMDI5ZGRiMTIxNDdmODg2Y2EwNzE2MTZlNjViMzgiLCJ2IjoiMSJ9",
        "view": "v_fountain_news",
        "view_version": "1",
        "row_count": 100,
        "window_days": 3,
        "bytes_scanned": 10113494,
        "credits": 8,
        "price_per_100_rows": 8,
        "sig": "GCEWDeRpkk38WS444-GrSuVc1GWS0Om1Nuvycbkfn3jxu7v3Pm2YB5LYDMeWKTKRQUuqZUhYANLpGQtMGHluBA",
        "public_key": "bMUigy8O0jOnBxQ4Sc-5lwhIZ8LQVAhxMbR7qESVuUE",
        "signer_path": "lakehouse/data-extract/v1",
        "alg": "Ed25519",
        "signed": true
      }
    },
    "written_at": "2026-09-03T00:36:49.951Z"
  },
  "cited_facts": [
    {
      "statement": "Thyme Care announced a new Series E financing round of over $125 million.",
      "source": "Cision PR Newswire",
      "instrument": "News",
      "claim_key": null,
      "published_at": "2026-09-02T15:00:00.000Z",
      "publisher_count": 1,
      "sources": [
        "Cision PR Newswire"
      ]
    },
    {
      "statement": "Morgan Health led the financing round with participation from Humana, CVS Health Ventures, AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures, and a16z Bio + Health.",
      "source": "Cision PR Newswire",
      "instrument": "News",
      "claim_key": null,
      "published_at": "2026-09-02T15:00:00.000Z",
      "publisher_count": 1,
      "sources": [
        "Cision PR Newswire"
      ]
    },
    {
      "statement": "Thyme Care is establishing Thyme Companies, a newly formed parent entity designed to build a portfolio of new, independent businesses in oncology.",
      "source": "Cision PR Newswire",
      "instrument": "News",
      "claim_key": null,
      "published_at": "2026-09-02T15:00:00.000Z",
      "publisher_count": 1,
      "sources": [
        "Cision PR Newswire"
      ]
    },
    {
      "statement": "Thyme Care services are currently available to more than 10.5 million people across all 50 states.",
      "source": "Cision PR Newswire",
      "instrument": "News",
      "claim_key": null,
      "published_at": "2026-09-02T15:00:00.000Z",
      "publisher_count": 1,
      "sources": [
        "Cision PR Newswire"
      ]
    },
    {
      "statement": "Thyme Care is forming a new parent company called Thyme Companies to address disconnections in how cancer care is delivered, accessed, and paid for.",
      "source": "CNBC",
      "instrument": "News",
      "claim_key": null,
      "published_at": "2026-09-02T15:15:25.000Z",
      "publisher_count": 1,
      "sources": [
        "CNBC"
      ]
    },
    {
      "statement": "Thyme Care's valuation reached more than $2 billion following the Series E round, roughly doubling its valuation from a Series D less than a year ago.",
      "source": "CNBC",
      "instrument": "News",
      "claim_key": null,
      "published_at": "2026-09-02T15:15:25.000Z",
      "publisher_count": 1,
      "sources": [
        "CNBC"
      ]
    }
  ],
  "note": "A signature proves who filed this and that it has not changed since. It never makes a claim true."
}